R1 RCM Inc. (NASDAQ:RCM) Receives $15.41 Consensus Target Price from Brokerages

R1 RCM Inc. (NASDAQ:RCM) has been assigned a consensus rating of “Hold” from the eighteen brokerages that are covering the firm, Marketbeat reports. Thirteen research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $15.41.

Several equities analysts have weighed in on RCM shares. Robert W. Baird reissued an “outperform” rating and set a $18.00 price objective on shares of R1 RCM in a report on Tuesday, July 2nd. Stephens downgraded R1 RCM from an “overweight” rating to an “equal weight” rating in a research note on Thursday, August 1st. Royal Bank of Canada restated an “outperform” rating and issued a $19.00 price objective on shares of R1 RCM in a research note on Friday, June 28th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $14.30 price objective on shares of R1 RCM in a report on Tuesday, August 20th. Finally, Jefferies Financial Group downgraded shares of R1 RCM from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st.

Institutional Trading of R1 RCM

Institutional investors and hedge funds have recently modified their holdings of the business. Bardin Hill Management Partners LP increased its holdings in shares of R1 RCM by 98.7% in the 2nd quarter. Bardin Hill Management Partners LP now owns 525,211 shares of the healthcare provider’s stock worth $6,597,000 after buying an additional 260,891 shares during the last quarter. Scientech Research LLC purchased a new position in R1 RCM in the second quarter worth $285,000. Sea Cliff Partners Management LP increased its stake in R1 RCM by 14.3% in the second quarter. Sea Cliff Partners Management LP now owns 2,437,450 shares of the healthcare provider’s stock valued at $30,614,000 after acquiring an additional 305,672 shares during the last quarter. Millennium Management LLC raised its position in R1 RCM by 8.1% during the second quarter. Millennium Management LLC now owns 457,907 shares of the healthcare provider’s stock valued at $5,751,000 after purchasing an additional 34,475 shares in the last quarter. Finally, Dark Forest Capital Management LP raised its position in R1 RCM by 67.5% during the second quarter. Dark Forest Capital Management LP now owns 57,749 shares of the healthcare provider’s stock valued at $725,000 after purchasing an additional 23,270 shares in the last quarter. Hedge funds and other institutional investors own 61.10% of the company’s stock.

R1 RCM Price Performance

Shares of NASDAQ:RCM opened at $14.12 on Friday. The company has a market capitalization of $5.95 billion, a P/E ratio of -176.50 and a beta of 0.84. The company’s 50-day moving average is $13.52 and its 200 day moving average is $13.00. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.84 and a current ratio of 1.84. R1 RCM has a fifty-two week low of $8.87 and a fifty-two week high of $17.17.

R1 RCM (NASDAQ:RCM) last released its earnings results on Wednesday, August 7th. The healthcare provider reported ($0.02) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.03. R1 RCM had a negative net margin of 1.68% and a negative return on equity of 1.44%. The firm had revenue of $627.90 million for the quarter, compared to analysts’ expectations of $633.10 million. R1 RCM’s revenue was up 12.0% on a year-over-year basis. On average, equities research analysts forecast that R1 RCM will post -0.24 earnings per share for the current year.

About R1 RCM

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.